AirSculpt Technologies (AIRS) Stock Price, News & Analysis

Company Overview

AirSculpt Technologies, Inc. operates a network of medical aesthetic clinics under the AirSculpt brand. The company specializes in minimally invasive body-contouring procedures designed to remove unwanted fat and improve body definition, with services provided by plastic surgeons and other qualified medical professionals.

Its primary offering is the AirSculpt procedure, a proprietary approach to liposuction that uses small cannulas and is generally performed while the patient is awake under local anesthesia. The company also offers related procedures, including fat transfer and sculpting for areas such as the abdomen, arms, thighs, buttocks and chin, as well as selected breast and facial treatments. AirSculpt clinics may additionally provide nonsurgical aesthetic services and skin-tightening treatments.

AirSculpt Technologies was founded by plastic surgeon Aaron Rollins and has expanded from its early U.S. operations into a broader clinic network serving customers in the United States and Canada. The company became publicly traded on the Nasdaq following a business combination completed in 2021.

Key Stats

• Today's Range: $1.59 to $1.69
• 50-Day Range: $1.62 to $5.01
• 52-Week Range: $1.51 to $12.00
• Volume: 1.02 million shs
• Average Volume: 931,241 shs
• Market Capitalization: $116.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.50
• Consensus Rating: Reduce

AirSculpt Technologies Stock Analysis - MarketRank™

AirSculpt Technologies scored higher than 36% of companies evaluated by MarketBeat, and ranked 770th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Reduce

Consensus Rating

AirSculpt Technologies has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

AirSculpt Technologies has a consensus price target of $4.50, representing about 177.8% upside from its current price of $1.62.

Amount of Analyst Coverage

AirSculpt Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

AirSculpt Technologies has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.52% of the float of AirSculpt Technologies has been sold short.

Short Interest Ratio / Days to Cover

AirSculpt Technologies has a short interest ratio ("days to cover") of 3.33, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AirSculpt Technologies has recently decreased by 2.12%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AirSculpt Technologies does not currently pay a dividend.

Dividend Growth

AirSculpt Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.46

News Sentiment

AirSculpt Technologies has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for AirSculpt Technologies this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for AIRS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AirSculpt Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

44.60% of the stock of AirSculpt Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

91.54% of the stock of AirSculpt Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NASDAQ:AIRS
• CIK: 1870940
• Web: www.airsculpt.com
• Phone: 786-709-9690
• Fax: N/A
• Employees: 363
• Year Founded: 2012

Price Target and Rating

• Average Price Target for AirSculpt Technologies: $4.50
• High Price Target: $4.50
• Low Price Target: $4.50
• Potential Upside/Downside: +177.8%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.67 million
• Net Margins: -7.79%
• Pretax Margin: -11.76%
• Return on Equity: -5.83%
• Return on Assets: -2.88%

Debt

• Debt-to-Equity Ratio: 0.32
• Current Ratio: 0.79
• Quick Ratio: 0.79

Sales & Book Value

• Annual Sales: $151.82 million
• Price / Sales: 0.77
• Cash Flow: $0.02 per share
• Price / Cash Flow: 90.80
• Book Value: $1.40 per share
• Price / Book: 1.16

Miscellaneous

• Outstanding Shares: 72,100,000
• Free Float: 39,941,000
• Market Cap: $116.80 million
• Optionable: Optionable
• Beta: 2.29